ICCM News and Press, IceCure Medical Ltd. From 03/27/24

IceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024 IceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024 PR Newswire Overview of U.S. Commercial Strategy will be Discussed on Conference Ca...

IceCure Medical Reports Positive Topline Results From ICE3 Cryoablation Breast Cancer Study: Achievement of 96.39% Recurrence Free Rate Brings Company One Step Closer to Providing Women a Non-Surgical Alternative to Lumpectomy PR Newswire Expects to submit full dataset to ...

IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogen Flow Control to Optimize Patient Outcomes PR Newswire Innovating as a global leader in cryoablation technologies, with 42 patents issued and allowed Cryogenic flow control enhances th...

IceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech & Services Conference IceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech & Services Conference PR Newswire CAESAREA, Israel , March 7, 2024 /PRNewswire/ -- ...

IceCure's ProSense® a Promising Alternative Treatment for Extra-Pelvis Endometriosis: Independent Study Presented at ECR 2024 PR Newswire MRI reveals disappearance of hemorrhagic signal and development of necrotic changes Pain reduced from a median of 7 on...

Fourth BRIIT Conference in India Features IceCure's ProSense® in Breast Cancer Imaging & Interventions Workshop Fourth BRIIT Conference in India Features IceCure's ProSense® in Breast Cancer Imaging & Interventions Workshop PR Newswire Session conducted...

Study Using IceCure's ProSense® Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer PR Newswire Independent study in women deemed inoperable for breast cancer reports median tumor reduction of 100% at 6 and 12 months following cryoablation ...

IceCure's ProSense® to be Featured at Two Upcoming Medical Conferences in Japan PR Newswire CAESAREA, Israel , Feb. 15, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minim...

2024-01-31 08:28:40 ET Losers: Remark Holdings ( MARK ) -46% . Nuvve Holding Corp ( NVVE ) -30% . New York Community Bancorp NYCB -26% after Q4 earnings release . Mmtec ( MTC ) -18% . Extreme Networks EXTR -4% after Q2 earnings rel...

2024-01-30 17:23:08 ET More on IceCure Medical IceCure Medical Ltd (ICCM) Q3 2023 Earnings Call Transcript IceCure shares rally 53% on ProSense kidney cancer study IceCure stock climbs 10% amid FDA appeal, earnings report Seeking Alpha’s Quant Rating o...